Navigation Links
Prescient Medical, Inc. CEO Patricia Scheller to Speak at 'The Value of Innovation in Health Care,' a Galen Institute Conference

DOYLESTOWN, Pa., Dec. 7 /PRNewswire/ -- Patricia Scheller, CEO of Prescient Medical, Inc., will be among the speakers at the Galen Institute's "The Value of Innovation in Health Care" conference. The conference will take place on Wednesday, December 9th in Washington DC at the Columbus Club at Union Station.

The Galen Institute is a non-profit public policy research organization focusing on health and tax policy.

"I'm very pleased to be part of the Galen Institute's conference," said Ms. Scheller. "As the debate on health care reform continues, there appears to be bipartisan agreement that continued innovation in medical research and the development of pioneering medical technology is critical. The US has historically led the world in advancing medical progress and the policy initiatives being discussed have the potential to profoundly impact our future position. The Galen Institute's conference offers a wonderful opportunity to provide input to lawmakers on how their policies can promote innovation."

The event unites policy experts, elected officials, and leaders in a number of health care-related industries to discuss the effects of health care reform on innovation. Prescient Medical has developed two breakthrough interventional cardiology solutions: the vProtect(TM) Luminal Shield and the vPredict(TM) Optical Catheter System.

The vProtect(TM) Luminal Shield is a novel self-expanding coronary stent-like Shield that received CE Mark certification in August, 2009, allowing it to be marketed in Europe for improving coronary artery luminal diameter in patients with symptomatic ischemic heart disease. The Shield was recently honored with Frost & Sullivan's 2009 North American Product Innovation of the Year Award. Designed specifically to minimize arterial injury and its consequences, the Shield is ideal for treating softer plaques, such as those that are typically associated with heart attacks.

The vPredict(TM) Optical Catheter System is being developed for the detection and characterization of soft plaque. Its technology platform is based on Raman spectroscopy, a highly sensitive technique proven in numerous non-clinical applications. The vPredict(TM) System detects clinically important compounds, including cholesterols, in the vessel wall and plaque. The goal of the vPredict(TM) System is to provide physicians with information to identify patients at risk for a heart attack and treat them proactively.

For more information on Prescient Medical or its products, please contact Ilana Odess, General Manager of Prescient Medical, at:

About Prescient Medical, Inc.

Prescient Medical, Inc. is a privately held medical device company dedicated to reducing deaths from heart attacks, the leading cause of death in much of the world. The company is the recipient of the 2009 Frost and Sullivan Award for Product Innovation of the Year Award for vProtect(TM) Luminal Shield. For more information about Prescient Medical and its products, please visit

SOURCE Prescient Medical, Inc.

SOURCE Prescient Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Prescient Medical vProtect(TM) Luminal Shield Receives North American Product Innovation of the Year Award from Frost & Sullivan
2. Prescient Medical Inc. Featured on FOX Business Network
3. vProtect Luminal Shield (TM) from Prescient Medical Receives CE Mark
4. Prescient Medical Receives Frost & Sullivan Product Innovation of the Year Award
5. Momentum Women(TM) Honors Patricia Scheller of Prescient Medical for Commitment to Promoting Cardiovascular Disease Awareness
6. Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California)
7. Amalgamated Capital Serves as Syndication Agent in the Recapitalization of 180 Medical, Inc.
8. Entest BioMedical, Inc. Discusses How Therapies in Development May Yield Lucrative Revenue Streams for the Company
9. Solta Medical, Inc. Appoints Jeffrey Nardoci Vice President of Global Marketing
10. Trapeze Networks Announces Trapeze Medical, Bringing Medical-Grade Mobility to Healthcare Market
11. China Sky One Medical, Inc. Exports Pain Relief Patch to Canada
Post Your Comments:
(Date:12/1/2015)... ... 01, 2015 , ... Lutronic, a leading innovator of aesthetic and medical laser ... devices for sale in the United States. Clarity is a Superior Dual Wavelength ... lasers, into a single platform that is easy to own and operate. , ...
(Date:12/1/2015)... ... December 01, 2015 , ... With FCPX Overlay: Grit , users can ... customization, the possibilities are truly endless, all with a click of a mouse. Each ... flip, horizontal flip, depth of field and more, all within Final Cut Pro X. ...
(Date:11/30/2015)... ... 2015 , ... Third Molar SEO , one of ... launched a sleek, mobile-ready and user-centric redesigned website. , Vivek Srivastava, founder and ... the benefits that its SEO services provide to dentists and why Third Molar ...
(Date:11/30/2015)... (PRWEB) , ... December 01, 2015 , ... The ... 2015-2016 inductee into its VIP Woman of the Year Circle. She is recognized with ... leading networking organization exclusively for professional women, boasting more than 850,000 members and over ...
(Date:11/30/2015)... ... , ... Until now, the St. Louis Fetal Care Institute used ... Study) trial. One of these exclusion criteria was a BMI above 34.9. According to ... is considered normal, 25 - 29.9 is overweight and above 30 is obese. , ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Texas , Dec. 1, 2015 /PRNewswire/ ...  announced today that top-line data from its ... telotristat etiprate in treating carcinoid syndrome in ... with the clinical benefit observed in its ... designed as a companion to TELESTAR primarily ...
(Date:12/1/2015)... Colo. , Dec. 1, 2015 Ampio ... New York Stock Exchange has established January 5, 2016 as ... its stockholders of the shares of Common Stock of ... (1) share of Aytu common stock for every five ... the record date, December 1, 2015. The distribution date will ...
(Date:12/1/2015)... PUNE, India , December 1, 2015 ... defines and segments the concerned market with analysis and ... orthobiologics report defines and segments the concerned ... According to the Market Research Report "North American ... Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy, ...
Breaking Medicine Technology: